NYSE: RDY - Dr. Reddy's Laboratories

Yield per half year: -21.22%
Dividend yield: +1.77%
Sector: Healthcare

Share chart Dr. Reddy's Laboratories


About Dr. Reddy's Laboratories

Dr. Reddy’s (Dr. Reddy’s Laboratories) — международная индийская фармацевтическая компания со штаб-квартирой в Хайдарабаде, вторая по объёмам продаж лекарственных средств в Индии (2015, после Sun Farmaceuticals). Выпускает как дженерики (Цетрин, Экзифин), так и патентованные препараты (Ибуклин, Декспан Плюс, Кеторол-гель), также оказывает фармацевтические услуги, производит фармсубстанции. Основана в 1984 году доктором Анджи Редди (англ. Anji Reddy). Кроме национального, работает на международных рынках, в основном — в развивающихся странах.

more details
В России продукция фирмы присутствует с 1992 года, в 2003 году был создан собственный филиал со складом для обслуживания на территории России. В 2016-2017 годы компания начала освоение западноевропейского рынка, запустив продажи лекарственных средств в Италии, Испании, Франции.

IPO date 2001-04-11
ISIN US2561352038
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета inr
Див.доход ао 2.9
Дивиденд ао 0.9582
Сайт https://www.drreddys.com
Цена ао 12.53
Change price per day: 0% (12.53)
Change price per week: -3.54% (12.99)
Change price per month: -9.27% (13.81)
Change price per 3 month: -12.99% (14.4)
Change price per half year: -21.22% (15.906)
Change price per year: -16.73% (15.048)
Change price per 3 year: -77.05% (54.6)
Change price per 5 year: -79.43% (60.9)
Change price per 10 year: -76.75% (53.89)
Change price per year to date: -19.11% (15.49)

Underestimation

Title Value Grade
P/S 3.66 5
P/BV 3.64 5
P/E 18.33 7
EV/EBITDA 11.69 7
Total: 7

Efficiency

Title Value Grade
ROA, % 15.68 5
ROE, % 21.69 7
Total: 7

Dividends

Title Value Grade
Div yield, % 1.77 4.43
DSI 0.9286 9.29
Total: 4.55

Debt

Title Value Grade
Debt/EBITDA 0.2264 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 59.89 7
Yield Ebitda, % 78.53 8
Yield EPS, % 2320.45 10
Total: 7

Institutions Volume Share, %
Blackrock Inc. 3001420 1.8
Royal Bank of Canada 2219807 1.33
Renaissance Technologies, LLC 1860795 1.12
Goldman Sachs Group Inc 1837163 1.1
Robeco Institutional Asset Management B.V. 1725380 1.03
Aikya Investment Management Ltd 1096573 0.66
Vanguard Group Inc 1038258 0.62
Dimensional Fund Advisors LP 829310 0.5
Morgan Stanley 818552 0.49
Man Group PLC 765193 0.46



Head Job title Payment Year of birth
Mr. Gunupati Venkateswara Prasad B.E. Co-Chairman, MD & Member of Management Council 2.25M 1960 (65 years)
Mr. Erez Israeli M.B.A. CEO & Member of the Management Council N/A 1968 (57 years)
Mr. Deepak Sapra M.B.A. CEO of API & Services & Member of Management Council N/A 1975 (50 years)
Ms. Archana Bhaskar B.Sc., M.B.A. EVP, Head of Corporate Communications, Chief Human Resources Officer & Member of Management Council N/A 1967 (58 years)
Mr. Sanjay Sharma B.Tech. Executive VP, Global Head of Global Manufacturing & Member of Management Council N/A 1968 (57 years)
Mr. Patrick Aghanian B.A., M.B.A. CEO of European Generics & Member of Management Council N/A 1965 (60 years)
Mr. Kallam Satish Reddy B.Tech., M.S. Chairman of the Board & Member of the Management Council 1.38M 1967 (58 years)
Mr. Venkata Ramana Motupalli M.B.A. CEO of Branded Markets - India & Emerging Countries and Member of Management Council N/A 1969 (56 years)
Mr. Mannam Venkatanarasimham CFO & Member of the Management Council
Mr. Krishna K. Venkatesh B.Pharma M.S. Global Head of Quality and Pharmacovigilance & Member of the Management Council 1973 (52 years)

Address: India, Hyderabad, 8-2-337 Road No. 3 - open in Google maps, open in Yandex maps
Website: https://www.drreddys.com